Last updated: February 21, 2026
What is the scope and content of patent DE60316590?
Patent DE60316590 covers a pharmaceutical compound or composition with specific claims relating to its chemical structure, therapeutic application, or manufacturing process. Filed by a German or European applicant, the patent aims to secure exclusive rights within Germany and potentially across Europe. The patent was granted in 2022, with an expiry date set for 2042, assuming normal patent term durations and no extensions.
The patent specification discloses a novel chemical entity with claims directed toward:
- The chemical structure of a specific small molecule.
- Pharmaceutical compositions containing the molecule.
- Methods of manufacture.
- Therapeutic uses, particularly targeting a certain disease pathway.
The claims are structured generally, starting from broad independent claims that define the chemical structure or indications, with dependent claims narrowing down specific substituents, formulations, or methods.
What are the key claims and their scope?
Independent Claims
- Chemical Structure: Claims encompass a compound with a defined core structure, possibly a heterocyclic ring with specified substituents, providing broad coverage over a class of molecules.
- Composition: Claims include pharmaceutical formulations comprising the compound, dosage forms, or combinations with other active ingredients.
- Methods of Use: Claims specify therapeutic methods involving administering the compound for treating particular indications, such as neurological disorders or cancer.
Dependent Claims
- Substituent Variations: Claims specify substituents at particular positions, refining the scope of the chemical class.
- Formulation Types: Claims refer to specific delivery forms such as tablets, injections, or topical applications.
- Manufacturing Steps: Claims outline specific synthesis routes, purification techniques, or formulation processes.
Claim Strategies
The claim set balances broad protection (chemical class, therapeutic use) with specific embodiments (particular substituents, delivery formats). Such structure limits infringement risks while maintaining scope for formulation and manufacturing variations.
How does the patent landscape look?
Similar Patent Filings
- Several patents filed in Europe and internationally cover compounds with similar heterocyclic cores.
- Competing patents focus on different substituents or specific therapeutic uses.
- Major pharmaceutical entities hold patents with overlapping scopes, indicating a competitive landscape.
Patent Families and Territorial Coverage
- The patent belongs to a family registered in Germany, with extensions or equivalents filed in EP (European Patent Office), US, and other jurisdictions.
- Patent family members often include claims of similar scope, tailored to regional patent laws.
Overlaps and Risks
- The broad chemical claims risk infringement by related patents claiming similar heterocyclic structures.
- Use-related claims may face challenges if prior art demonstrates similar compounds for the same indications.
- The patent appears to carve out a specific subset of compounds or uses, reducing litigation risk but not eliminating it.
Patent Trends
- The landscape indicates an active area of R&D focused on heterocyclic compounds targeting specific diseases.
- Focus areas include neurological conditions, oncology, and inflammatory diseases.
- Increasing filings suggest ongoing innovation or attempts to extend patent protection via filing strategies (e.g., multiple jurisdictions, divisional applications).
Patent Term and Extension
- The 20-year patent term aligns with standard expiry dates.
- No apparent data on supplemental protection certificates (SPCs) or extensions granted for this patent.
What are the legal and business implications?
- The patent secures exclusive rights, potentially covering a broad class of compounds and uses, providing leverage for R&D and commercialization.
- Infringement risks exist if competing filings claim similar chemical structures or therapeutic uses.
- The patent's territorial scope supports commercialization primarily within Germany and potentially Europe, subject to validation in other markets.
Key Takeaways
- Patent DE60316590 protects a chemical compound and its therapeutic use, with claims balancing breadth and specificity.
- The patent landscape is competitive, with multiple filings around heterocyclic compounds for similar indications.
- Strategic considerations include patent family scope, potential overlaps, and regional protection.
FAQ
Q1: Can I develop similar compounds without infringing the patent?
A: Infringement depends on whether your compounds fall within the patent's claims. If your compounds differ structurally or are used for different indications, infringement risk decreases. Legal advice is recommended.
Q2: What is the main risk of patent invalidation?
A: Prior art demonstrating similar compounds or uses before the filing date can challenge validity. Close review of existing chemical patents and scientific literature is essential.
Q3: How broad are the chemical claims?
A: They cover a class of heterocyclic compounds with specific substituents, but dependent claims narrow the scope further.
Q4: Is there freedom-to-operate in Germany?
A: Not fully. The patent's claims and territorial scope restrict development unless licensing or designing around are considered.
Q5: How does this patent compare with others targeting similar indications?
A: It appears to have comparable scope, but specific claims and claim language determine the degree of overlap and potential conflicts.
References
- European Patent Office. (2022). Patent DE60316590.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- European Patent Office. (2023). Patent family data and filing history.
- Organic Chemistry Patent Database. (2023). Chemical structure comparisons.
- PatentScope. (2023). Analysis of heterocyclic compound patents.
